Controlling and ultimately ending the HIV/AIDS pandemic: A feasible goal

JAMA

Volumn 304, Issue 3, 2010, Pages 350-351

  Folkers, Gregory K ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BEHAVIOR MODIFICATION; BLOOD TRANSFUSION; CIRCUMCISION; CLINICAL PRACTICE; CONDOM; COST EFFECTIVENESS ANALYSIS; EDITORIAL; EVIDENCE BASED PRACTICE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH EDUCATION; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INTRAVENOUS DRUG ABUSE; NEEDLE; NONHUMAN; PANDEMIC; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAFE SEX; UNITED STATES;

EID: 77954699449     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.957     Document Type: Editorial

References (15)

1. Centers for Disease Control (CDC). Pneumocystis pneumonia: Los Angeles. MMWR Morb Mortal Wkly Rep. 1981;30(21):250-252.
2. Centers for Disease Control (CDC). Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men: New York City and California.MMWRMorb Mortal Wkly Rep. 1981;30(25):305-308.
3. Gallo RC, Montagnier L. The discovery of HIV as the cause of AIDS. N Engl J Med. 2003;349(24):2283-2285.
4. AIDS epidemic update 2009. Joint United Nations Programme on HIV/AIDS (UNAIDS). http://www.who.int/hiv/pub/epidemiology/epidemic/en/index.html. Accessed June 13, 2010.
5. Clinical guidelines portal. US Dept of Health and Human Services. http://www.aidsinfo.nih.gov. Accessed June 23, 2010.
6. Antiretroviral therapy. World Health Organization (WHO). http://www.who.int/hiv/topics/treatment/en. Accessed June 13, 2010.
7. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293-299.
8. van Sighem AI, Gras LA, Reiss P, Brinkman K, de Wolf F; ATHENA National Observational Cohort Study. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS. 2010;24(10):1527-1535.
9. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375(9731):2092-2098.
10. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.
11. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoSOne. 2010;5(6):e11068.
12. Centers for Disease Control and Prevention (CDC). Late HIV testing: 34 states, 1996-2005. MMWR Morb Mortal Wkly Rep. 2009;58(24):661-665.
13. Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397-1404.
14. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48-57.
15. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al; MOPH-TAVEG Investigators. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361(23):2209-2220.